Zno nanostructures for drug delivery and theranostic applications

195Citations
Citations of this article
287Readers
Mendeley users who have this article in their library.

Abstract

In the last two decades, zinc oxide (ZnO) semiconductor Quantum dots (QDs) have been shown to have fantastic luminescent properties, which together with their low-cost, low-toxicity and biocompatibility have turned these nanomaterials into one of the main candidates for bio-imaging. The discovery of other desirable traits such as their ability to produce destructive reactive oxygen species (ROS), high catalytic efficiency, strong adsorption capability and high isoelectric point, also make them promising nanomaterials for therapeutic and diagnostic functions. Herein, we review the recent progress on the use of ZnO based nanoplatforms in drug delivery and theranostic in several diseases such as bacterial infection and cancer.

Cite

CITATION STYLE

APA

Martínez-Carmona, M., Gun’Ko, Y., & Vallet-Regí, M. (2018, April 23). Zno nanostructures for drug delivery and theranostic applications. Nanomaterials. MDPI AG. https://doi.org/10.3390/nano8040268

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free